Search Results

You are looking at 1 - 10 of 220 items for :

  • molecular features x
Clear All
Open access

Catarina Tavares, Maria João Coelho, Catarina Eloy, Miguel Melo, Adriana Gaspar da Rocha, Ana Pestana, Rui Batista, Luciana Bueno Ferreira, Elisabete Rios, Samia Selmi-Ruby, Bruno Cavadas, Luísa Pereira, Manuel Sobrinho Simões and Paula Soares

analysis, in a large series of primary thyroid carcinomas and looked for possible associations with some clinicopathological and molecular features, as well as to the response to RAI therapy and outcome. In order to validate our results of SLC5A5 mRNA

Open access

Klaudia Zajkowska, Janusz Kopczyński, Stanisław Góźdź and Aldona Kowalska

encapsulated. The encapsulated variant of FVPTC (EFVPTC) may exhibit features of vascular or capsular invasion ( Fig. 1 ). Individual forms of FVPTC differ in molecular profile, clinical behaviour and prognosis ( 2 , 3 ). Evidence suggests that among different

Open access

Ana Carolina de Jesus Paniza, Thais Biude Mendes, Matheus Duarte Borges Viana, Débora Mota Dias Thomaz, Paula B O Chiappini, Gabriel A Colozza-Gama, Susan Chow Lindsey, Marcos Brasilino de Carvalho, Venâncio Avancini Ferreira Alves, Otavio Curioni, André Uchimura Bastos and Janete Maria Cerutti

the presence of more aggressive histological features or even the presence of papillae and help to exclude the diagnosis of NIFTP ( 18 , 26 , 31 , 32 , 33 , 34 , 35 , 36 ). As there is no association between a specific molecular profile and the

Open access

Jordyn Silverstein, Wesley Kidder, Susan Fisher, Thomas A Hope, Samantha Maisel, Dianna Ng, Jessica Van Ziffle, Chloe E Atreya and Katherine Van Loon

mode of presentation, outcomes of the mother and fetus and treatment decisions ( 18 ). None of these prior studies have evaluated relevant factors of disease biology or molecular features of the tumors. Following our observation of five women who

Open access

A H Ludwig-Slomczynska, S Borys, M T Seweryn, J Hohendorff, P Kapusta, B Kiec-Wilk, E Pitera, P P Wolkow and M T Malecki

molecular and clinical features . Blood 2014 3007 – 3015 . ( https://doi.org/10.1182/blood-2013-12-544809 ) 38 Braun S Hanselmann C Gassmann MG auf dem Keller U Born-Berclaz C Chan K Kan YW Werner S . Nrf2 transcription factor, a

Open access

Sandrine Visentin, Gérard Michel, Claire Oudin, Béatrice Cousin, Bénédicte Gaborit, Inès Abdesselam, Marie Maraninchi, Marion Nowicki, René Valéro, Maxime Guye, Monique Bernard, Pascal Auquier, Hervé Chambost, Marie-Christine Alessi and Sophie Béliard

 = 1000 ms, echo time = 35 ms, number of excitations = 16, and bandwidth of 2000 Hz) was used to determine the molecular content of lipids and water. A spectroscopic voxel was positioned in three different orientations (axial, coronal and sagittal

Open access

Caio Jordão Teixeira, Junia Carolina Santos-Silva, Dailson Nogueira de Souza, Alex Rafacho, Gabriel Forato Anhe and Silvana Bordin

delivery with a coinciding increase in apoptosis and reduction of cellular proliferation. Notably, we revealed that morphological features of pancreatic islet neogenesis sequentially and transiently appear in the maternal pancreas 8 days after delivery

Open access

Huy Gia Vuong, Nguyen Phuoc Long, Nguyen Hoang Anh, Tran Diem Nghi, Mai Van Hieu, Le Phi Hung, Tadao Nakazawa, Ryohei Katoh and Tetsuo Kondo

those PTCs having the features of TCs but do not reach the cut-off percentage criteria ( 6 , 8 ). Because of these continuing debates, we need to identify an appropriate threshold of TCs to use in the diagnosis of TCVPTC. The purpose of this meta

Open access

L A Hughes, K McKay-Bounford, E A Webb, P Dasani, S Clokie, H Chandran, L McCarthy, Z Mohamed, J M W Kirk, N P Krone, S Allen and T R P Cole

Introduction Disorders of sex development (DSD) encompass a wide range of conditions with diverse clinical features, pathophysiology and clinical management ( 1 , 2 , 3 ). The recently revised stratified DSD diagnostic pathway consists of

Open access

Changjiao Yan, Meiling Huang, Xin Li, Ting Wang and Rui Ling

to 1997 and 6.6% from 1997 to 2009 ( 2 )). In addition, recurrence and metastases are common for a small proportion of PTCs who reach advanced disease stages ( 4 ). In recent years, molecular markers have received extensive attention to improving risk